BiolineRx
Committed to developing novel compounds in oncology that will deliver life-changing innovations for patients.
Launch date
Employees
Market cap
$54.0m
Enterprise valuation
$45m (Public information from Sep 2024)
Share price
$0.65 BLRX
Jerusalem Jerusalem District (HQ)
Authorizing premium user...